发明名称 SUBSTITUTED BENZENESULPHONAMIDE DERIVATIVES AS PRECURSORS OF COX-2 INHIBITORS
摘要 The COX-2 inhibitor precursors are successfully used in the treatment of inflammations and conditions caused by them. They have the formula where A is optionally substituted in a position in which it can be substituted with one or more radicals selected amongst alkylcarbonyl, formyl, halo, alkyl, haloalkyl, oxo, cyano, nitro, carboxy, alkoxy, aminocarbonyl, alkoxycarbonyl, carboxyalkyl, cyanoalkyl, hydroxyalkyl, haloalkylsulphonyloxy, alkoxyalkyloxyalkyl, carboxyalkoxyalkyl, cycloalkylalkyl, alkenyl, alkynyl, heterocyclyloxy, alkylthio, cycloalkyl, aryl, heterocyclyl, cycloalkenyl, aralkyl, heterocyclylalkyl, alkylthioalkyl, arylcarbonyl, aralkylcarbonyl, aralkenyl, alkoxyalkyl, arylthioalkyl, aryloxyalkyl, aralkylthioalkyl, aralkoxyalkyl, alkoxycarbonylalkyl, aminocarbonylalkyl, alkylaminocarbonyl, N-arylaminocarbonyl, N-alkyl.N-arylaminocarbonyl, alkylaminocarbonylalkyl, alkylamino, N-arylamino, N-aralkylamino, N-alkyl-N-aralkylamino, N-alkyl-N-arylamino, aminoalkyl, alkylaminoalkyl, N-arylaminoalkyl, N-aralkylaminoalkyl, N-alkyl-N-aralkylaminoalkyl, N-alkyl-N-arylaminoalkyl, aryloxy, aralcoxy, aralkylthio, alkylsulphanyl, alkylsulphonyl, aminosulphonyl, alkylaminosulphonyl, N-arylaminosulphonyl, arylsulphonyl and N-alkyl-N-arylaminosulphonyl, R1 is selected amongst heterocaclyl, cycloalkyl, cycloalkyenyl and aryl, R1 optionally being substituted in a position where it can be substituted by one or more radical selected amongst alkyl, haloalkyl, cyano, carboxy, alkoxycarbonyl, hadroxy, hydroxyalkyl, haloalkoxy, amino, alkylamino, arylamino, nitro, alkoxyalkyl, alkylsulphonyl, halo, alkoxy and alkylthio. R being selected between hydrido and alkoxycarbonylalkyl, and R2 being selected amongst hydrido and alkoxycarbonylalkyl and R2 is selected amongst alkyl, carboxyalkyl,acyl, alkoxycarbonyl, heteroarylcarbonyl, alkoxycarbonylalkylcarbonyl, alkoxycarbonylcarbonyl, resude from amino acid and alkylcarbonylaminoalkylcarbonyl, A should not be tetrazole or pyridine radical and A should not be indanone when R3 is alkyl or carboxyalkyl or its pharmaceutically acceptable salt.
申请公布号 BG64531(B1) 申请公布日期 2005.06.30
申请号 BG19980102916 申请日期 1998.11.12
申请人 G.D.SEARLE & CO 发明人 TALLEY JOHN;MALECHA JAMES;BERTENSHAW STEPHEN;GRANETO MATTHEW;CARTER JEFFREY;LI JINGLIN;NAGARAJAN SRINIVASAN;BROWN DAVID;ROGIER JR. DONALD;PENNING THOMAS;KHANNA ISH;XU XIANGDONG;WEIER RICHARD
分类号 C07D233/64;A61K31/00;A61K31/18;A61K31/34;A61K31/341;A61K31/365;A61K31/40;A61K31/415;A61K31/4162;A61K31/4164;A61K31/42;A61K31/421;A61K31/44;A61K31/4427;A61K31/4439;A61K31/635;A61P1/02;A61P1/04;A61P3/10;A61P5/16;A61P7/06;A61P9/10;A61P11/02;A61P11/06;A61P11/08;A61P13/12;A61P15/06;A61P17/02;A61P17/04;A61P17/06;A61P19/02;A61P19/08;A61P21/00;A61P21/04;A61P25/00;A61P25/04;A61P25/28;A61P27/02;A61P27/12;A61P29/00;A61P29/02;A61P31/12;A61P35/00;A61P37/00;A61P43/00;C07C311/16;C07C311/39;C07C311/51;C07D;C07D207/32;C07D207/327;C07D207/33;C07D231/12;C07D233/54;C07D233/62;C07D261/08;C07D263/32;C07D307/46;C07D307/58;C07D401/04;C07D417/04;C07D495/04;(IPC1-7):C07D261/08 主分类号 C07D233/64
代理机构 代理人
主权项
地址